Works matching DE "FOLLICULAR lymphoma"
Results: 655
Rituximab‐associated colitis mimicking ulcerative colitis.
- Published in:
- Digestive Endoscopy, 2025, v. 37, n. 3, p. 295, doi. 10.1111/den.14982
- By:
- Publication type:
- Article
A Novel Step‐Up Dosage Regimen for Enhancing the Benefit‐to‐Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular Lymphoma.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 465, doi. 10.1002/cpt.3445
- By:
- Publication type:
- Article
Acalabrutinib in combination with rituximab and lenalidomide in patients with relapsed or refractory follicular lymphoma: Results of the phase 1b open‐label study (ACE‐LY‐003).
- Published in:
- British Journal of Haematology, 2025, v. 206, n. 3, p. 887, doi. 10.1111/bjh.19951
- By:
- Publication type:
- Article
Treating asymptomatic follicular lymphoma: What is the score?
- Published in:
- British Journal of Haematology, 2025, v. 206, n. 3, p. 1018, doi. 10.1111/bjh.19949
- By:
- Publication type:
- Article
Quality of life in advanced‐stage, asymptomatic, non‐bulky follicular lymphoma treated with rituximab shows significant improvement compared with watchful‐waiting.
- Published in:
- British Journal of Haematology, 2025, v. 206, n. 3, p. 876, doi. 10.1111/bjh.19918
- By:
- Publication type:
- Article
A phase II study of zandelisib in patients with relapsed or refractory indolent non‐Hodgkin lymphoma: ME‐401‐K02 study.
- Published in:
- British Journal of Haematology, 2025, v. 206, n. 2, p. 541, doi. 10.1111/bjh.19994
- By:
- Publication type:
- Article
Prognostication of Follicular Lymphoma: A Review of Prognostic Scores and Factors.
- Published in:
- Diagnostics (2075-4418), 2025, v. 15, n. 5, p. 647, doi. 10.3390/diagnostics15050647
- By:
- Publication type:
- Article
Synchronous multiple primary cancers involving cervical cancer and follicular lymphoma: A case report.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Treatment of primary esophageal lymphomas: A review.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1475153
- By:
- Publication type:
- Article
Borrelia spielmanii--Associated Neuroborreliosis in Patient Receiving Rituximab, Belgium.
- Published in:
- Emerging Infectious Diseases, 2025, v. 31, n. 2, p. 341, doi. 10.3201/eid3102.240777
- By:
- Publication type:
- Article
The Predictive Role of Baseline 18 F-FDG PET/CT Radiomics in Follicular Lymphoma on Watchful Waiting: A Preliminary Study.
- Published in:
- Diagnostics (2075-4418), 2025, v. 15, n. 4, p. 432, doi. 10.3390/diagnostics15040432
- By:
- Publication type:
- Article
The association between radiotherapy and the prognosis of follicular lymphoma patients with different characteristics in the rituximab era: a cohort study based on Surveillance, Epidemiology and End Results.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 691, doi. 10.1007/s00277-025-06209-0
- By:
- Publication type:
- Article
Long-term remission following CAR-T therapy in a patient with transformed follicular lymphoma relapse after allogeneic stem cell transplantation.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 841, doi. 10.1007/s00277-024-06150-8
- By:
- Publication type:
- Article
Integrated analysis of transcriptome, methylome and copy number aberrations data of marginal zone lymphoma and follicular lymphoma in dog.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 4, p. 645, doi. 10.1111/vco.12588
- By:
- Publication type:
- Article
Differential survival of systemic B-cell lymphomas initially diagnosed in the skin: a population-based study of 883 patients.
- Published in:
- Archives of Dermatological Research, 2023, v. 315, n. 2, p. 259, doi. 10.1007/s00403-021-02293-0
- By:
- Publication type:
- Article
Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostat.
- Published in:
- NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-00826-8
- By:
- Publication type:
- Article
Single-cell landscape of primary central nervous system diffuse large B-cell lymphoma.
- Published in:
- Cell Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41421-023-00559-7
- By:
- Publication type:
- Article
Follicular lymphoma with secondary central nervous system relapse: a case report and literature review.
- Published in:
- Oxford Medical Case Reports, 2023, v. 2023, n. 11, p. 1, doi. 10.1093/omcr/omad118
- By:
- Publication type:
- Article
A Case of Lymphoma with Multiple Identities.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target.
- Published in:
- Blood Cancer Journal, 2025, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01041-7
- By:
- Publication type:
- Article
A comparative analysis of transformed indolent lymphomas and de novo diffuse large B-cell lymphoma: a population-based cohort study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01194-5
- By:
- Publication type:
- Article
Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01150-3
- By:
- Publication type:
- Article
Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01124-5
- By:
- Publication type:
- Article
Identification of genetic subtypes in follicular lymphoma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01111-w
- By:
- Publication type:
- Article
Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01041-7
- By:
- Publication type:
- Article
T-cell phenotype including CD57<sup>+</sup> T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00899-3
- By:
- Publication type:
- Article
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00847-1
- By:
- Publication type:
- Article
Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00620-w
- By:
- Publication type:
- Article
Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-021-00598-x
- By:
- Publication type:
- Article
Risk of second primary malignancies in patients with follicular lymphoma: a population-based study in the Netherlands, 1989-2018.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00546-9
- By:
- Publication type:
- Article
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00542-z
- By:
- Publication type:
- Article
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00525-0
- By:
- Publication type:
- Article
Budget Impact of Introducing Fixed-Duration Mosunetuzumab for the Treatment of Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy in the USA.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 569, doi. 10.1007/s40273-024-01358-y
- By:
- Publication type:
- Article
Lifetime Costs for Treated Follicular Lymphoma Patients in the US.
- Published in:
- PharmacoEconomics, 2021, v. 39, n. 10, p. 1163, doi. 10.1007/s40273-021-01052-3
- By:
- Publication type:
- Article
FDG-PET/CT Provides Clues on Bone Marrow Involvement in Follicular Lymphoma and Carries Important Prognostic Information.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 14, p. 2726, doi. 10.7150/jca.87523
- By:
- Publication type:
- Article
Aspiration Pneumonia Leading to Clostridium ramosum Bacteremia in a Neutropenic Patient: Case Report and Management Strategy.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02595-0
- By:
- Publication type:
- Article
The follicular lymphoma epigenome regulates its microenvironment.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-021-02234-9
- By:
- Publication type:
- Article
Radiological and pathological correlation of a rare case of primary breast follicular lymphoma in a male patient, presenting as gynaecomastia.
- Published in:
- Journal of Medical Imaging & Radiation Oncology, 2022, v. 66, n. 1, p. 107, doi. 10.1111/1754-9485.13183
- By:
- Publication type:
- Article
A case report of giant primary esophageal follicular lymphoma.
- Published in:
- Journal of Digestive Diseases, 2022, v. 23, n. 11, p. 660, doi. 10.1111/1751-2980.13147
- By:
- Publication type:
- Article
Synchronous in situ follicular neoplasia with MALT lymphoma and intramucosal adenocarcinoma in the stomach: A case report.
- Published in:
- Journal of Digestive Diseases, 2022, v. 23, n. 8, p. 546, doi. 10.1111/1751-2980.13132
- By:
- Publication type:
- Article
Primary head and neck lymphoid neoplasms in adolescents and young adults: demographics, distribution and survival outcomes.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 12, p. 5871, doi. 10.1007/s00277-024-06141-9
- By:
- Publication type:
- Article
Advances in epigenetic therapies for B-cell non-hodgkin lymphoma.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 12, p. 5085, doi. 10.1007/s00277-024-06131-x
- By:
- Publication type:
- Article
In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumab.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 12, p. 5861, doi. 10.1007/s00277-024-06130-y
- By:
- Publication type:
- Article
A brisk peripheral T-cell reaction following rituximab treatment for follicular lymphoma.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Is radiotherapy still the optimal initial choice for patients with early-stage low-grade follicular lymphoma in the modern era? A population-based study.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 11, p. 4589, doi. 10.1007/s00277-024-06022-1
- By:
- Publication type:
- Article
Vaginal involvement as a rare extranodal manifestation in advanced-stage follicular lymphoma: a case report and literature review.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 11, p. 4773, doi. 10.1007/s00277-024-05950-2
- By:
- Publication type:
- Article
Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for management.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 3, p. 905, doi. 10.1007/s00277-023-05569-9
- By:
- Publication type:
- Article
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 1, p. 185, doi. 10.1007/s00277-023-05475-0
- By:
- Publication type:
- Article